Finance

Beta
Lists
ANGO:NASDAQ
AngioDynamics, Inc.
$11.94
-0.75%
(-0.090) 1D
$11.94
0.00% (0.00)
After hours
Closed: Jun 5, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ANGO...
Open
$12.04
High
$12.40
Low
$11.89
Mkt. cap
493.35M
Avg. vol.
285.04K
Volume
385.74K
52-wk high
$13.99
52-wk low
$8.36
EPS
-$0.76
Beta
0.38
Shares outstanding
41.32M
No. of employees
675
Open
$12.04
High
$12.40
Low
$11.89
Mkt. cap
493.35M
Avg. vol.
285.04K
Volume
385.74K
52-wk high
$13.99
52-wk low
$8.36
EPS
-$0.76
Beta
0.38
Shares outstanding
41.32M
No. of employees
675
Analyst outlook
Analyst Ratings
Based on 3 analysts giving stock ratings to ANGO in the past 3 months
Strong Buy
Buy
3
Hold
0
Sell
0
12 month forecast
Based on 3 Wall Street analysts offering 12 month price targets for ANGO in the last 3 months.
Highest
Current $11.94
$16.00 (+34.00%)
Average
$16.00 (+34.00%)
Lowest
$16.00 (+34.00%)
News stories
From sources across the web
About AngioDynamics, Inc.
CEOJames Clemmer
Employees675
FoundedFeb 9, 1988
Headquarters-
SectorMedical device
Last report
Apr 2, 2026
Fiscal period
Q3 2026
EPS / Est. (USD)
$0.02 / -$0.11
+118.18%beat
Revenue / Est. (USD)
78.42M / 76.77M
+2.16%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
May 2025
Aug 2025
Nov 2025
Feb 2026
Revenue
80.16M
75.71M
79.43M
78.42M
Cost of goods sold
37.94M
33.85M
34.65M
36.94M
Cost of revenue
37.94M
33.85M
34.65M
36.94M
Research and development expenses
6.50M
6.32M
7.63M
6.93M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
36.76M
40.78M
37.00M
38.31M
Operating expense
45.85M
49.76M
47.27M
47.91M
Total operating expenses
83.79M
83.61M
81.92M
84.85M
Operating income
-3.63M
-7.90M
-2.49M
-6.43M
Other non operating income
-325.00K
-178.00K
-128.00K
4.97M
EBT including unusual items
-6.11M
-10.84M
-6.36M
-8.07M
EBT excluding unusual items
-3.96M
-8.08M
-2.72M
-1.55M
Income tax expense
-60.00K
65.00K
-5.00K
12.00K
Effective tax rate
0.98%
-0.60%
0.08%
-0.15%
Other operating expenses
-
-
-
-
Net income
-6.05M
-10.90M
-6.35M
-8.08M
Net profit margin
-7.55%
-14.40%
-7.99%
-10.31%
Earnings per share
-0.03
-0.10
-
0.02
Interest and investment income
100.00K
-
-
12.00K
Interest expense
-97.00K
-4.00K
-102.00K
-100.00K
Net interest expenses
3.00K
-4.00K
-102.00K
-88.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-1.20M
-1.88M
3.26M
-838.00K
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more